INTERNATIONAL PATENT: HANGZHOU TIANLONG PHARMACEUTICAL CO., LTD., 杭州天龙药业有限公司 FILES APPLICATION FOR "MODIFICATION TEMPLATE FOR IMPROVING INHIBITORY EFFECT OF DOUBLE-STRANDED OLIGONUCLEOTIDE ON TARGET GENE, COMBINATION THEREOF AND USE THEREOF"

GENEVA, April 19 -- HANGZHOU TIANLONG PHARMACEUTICAL CO., LTD. (No. 430, Jianding Road, Shangcheng DistrictHangzhou, Zhejiang 310009), 杭州天龙药业有限公司 (中国浙江省杭州市上城区笕丁路430号) filed a patent application (PCT/CN2024/144646) for "MODIFICATION TEMPLATE FOR IMPROVING INHIBITORY EFFECT OF DOUBLE-STRANDED OLIGONUCLEOTIDE ON TARGET GENE, COMBINATION THEREOF AND USE THEREOF" on Dec 31, 2024. With publication no. WO/2025/077949, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Class...